<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>
<head>
<title>8 Antibiotics - other protein synthesis inhibitors</title>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
		<link href="../sgStyles2.css" rel="stylesheet" type="text/css">
		<csimport user="../../../pharmTox.data/InDesignPackages/8 antibiotics/story_916.incd" occur="27">
		
		</csimport>
		<csimport user="../../../pharmTox.data/InDesignPackages/8 antibiotics/story_945.incd" occur="21">
			
		</csimport>
		<csimport user="../../../pharmTox.data/InDesignPackages/8 antibiotics/story_1166.incd" occur="42">
			
		</csimport>
		<csimport user="../../../pharmTox.data/InDesignPackages/8 antibiotics/story_887.incd" occur="37">

		</csimport>
	</head>

<body>
<a id="top"></a>
<div id="text"><div id="sumbox"><div id="drugbox"><strong>commonly used drugs</strong><br>
none
		</div>
	</div>

		<p class="titleSG"></a>Protein synthesis inhibitors - minor drugs</p>
		
		<input type="Button" value="Previous Page" onClick="history.go(-1)">
		
		<p><a href="abProtSynIndx.html">mechanism diagram
					</a></p>
		<p class="titleSG">Avilamycin</p>
		<csobj csref="../../../pharmTox.data/InDesignPackages/8 antibiotics/story_887.incd" h="305" occur="37" t="Component" w="1140" g="incopy_default" s="">
			<p class="ParBodytext"><span style="font-weight: bold; ">Avilamycin</span> is only used to prevent necrotic enteritis in chickens. Avilamycins are oligosaccharides and are usually classified as orthosomycins. There are many closely related orthosomycins, such as the everninimicins, flambamycin, curamycin and sporosuracins, none of which are used clinically in humans or animals in NZ at the moment.</p>
			<p class="ParBodytext">Avilamycin binds to the bacterial 30S ribosomal subunit and inhibits the attachment of tRNA, in a similar manner to aminoglycosides. The avilamycins are only active against Gram positive bacteria.</p>
			<p class="ParBodytext">SCH27988 (Ziracin), an everninomicin which is very similar to avilamycin, looked promising at one time for Gram positive nosocomial infections in people. It was active against a wide range of multi resistant staphylococci, enterococci and streptococci, but has now been dropped for safety reasons.</p>
			<p class="ParBodytext">Avilamycin is used as a growth promoter in pigs and chickens overseas. Avilamycin is useful against <span style="font-style: italic; ">Cl. perfringens</span> (necrotic enteritis) which is resistant to bacitracin.</p>
			<p class="ParBodytext">There appears to be complete cross resistance between avilamycin and everninomycins in enterococci isolated from broiler chickens and pigs. Resistance appears to develop slowly, both <span style="font-style: italic; ">in vitro</span> and in the field.</p>
			<p class="ParBodytext">Avilamycin is the only growth promoter left for chickens in Europe, where it is now used by the thousands of tons. Any problems should show up quickly there (none so far). It is not used much in NZ - at the moment.</p>
		</csobj>
		<p class="titleSG">Fusidic acid</p>
		<csobj csref="../../../pharmTox.data/InDesignPackages/8 antibiotics/story_916.incd" h="183" occur="27" t="Component" w="1140" g="incopy_default" s="">
			<p class="Bodytext"><span style="font-weight: bold; ">Fusidic acid</span> is a lipophilic steroid antibiotic derived from the fungus <span style="font-style: italic; ">Fusidum coccineum</span>. It inhibits binding of aminoacyl tRNA to the ribosome so inhibiting protein synthesis. It may be bacteriostatic or bacteriocidal. It is usually used as the sodium salt (sodium fusidate).</p>
			<p class="Bodytext">It causes liver toxicity when given parenterally, so is usually given orally or topically. Oral fusidate is well absorbed and tends to be concentrated in bone. Effective against Gram positives, mainly staphs (including MRSA). Streps and enterococci are not susceptible. Also has some antiprotozoal and antiviral properties and immunosuppressant actions. It is often impregnated into wound dressings.</p>
			<p class="Bodytext">Resistance develops rapidly <span style="font-style: italic; ">in vitro</span>, but has not been a problem in real life so far.</p>
			<p class="Bodytext">Although it has been used for trivial infections in the past, it is starting to be reserved for MRSA in human medicine - vets beware.</p>
		</csobj>
		<p class="titleSG">Oxazolidines</p>
		<csobj csref="../../../pharmTox.data/InDesignPackages/8 antibiotics/story_945.incd" h="48" occur="21" t="Component" w="1140" g="incopy_default" s="">
			<p class="Bodytext">The oxazolidines are a completely new class of antibiotic - the first for many years. <span style="font-weight: bold; ">Linezolid</span> has just been approved in NZ for people. It is effective against all Gram positive organisms with no resistance reported so far. It is likely to be reserved in people for MRSA and VRE infections (its current use in NZ) and possibly multirresistant TB. <span style="font-weight: bold; ">Do not use in animals</span>.</p>
		</csobj>
		<p class="titleSG">Mupirocin</p>
		<csobj csref="../../../pharmTox.data/InDesignPackages/8 antibiotics/story_1166.incd" h="138" occur="42" t="Component" w="1140" g="incopy_default" s="">
			<p class="Bodytext"><span style="font-weight: bold; ">Mupirocin</span> inhibits bacterial protein synthesis by binding to isoleucyl tRNA synthetase. It is bacteriostatic at low concentrations and bacteriocidal at high concentrations.</p>
			<p class="Bodytext">It is only used topically as it is rapidly metabolised if absorbed.</p>
			<p class="Bodytext">It is mainly used against staphs (particularly MRSA) and streps, but also has activity against <span style="font-style: italic; ">Candida</span>.</p>
			<p class="Bodytext">In NZ, it was reserved for treating MRSA until recently, when widespread resistance has made it almost useless.</p>
		</csobj>

		
		<p>back to <a href="abProtSynIndx.html">protein synthesis inhibitors</a></p>
		<table width="90%" border="0" align="center">
  <tr>
				<td class="titleSG"><a href="abIndex.html" class="aTitle">8 Antibiotics index</a></td>
			</tr>
</table>
		<br>
<table width="90%" border="0" align="center">
  <tr align="center">
    <td>    <a href="../../indexpharm.html"><img src="../../PharmBut.gif" width="100" height="21" border="0"></a></td>
    <td><a href="../../toxSite/indexTox.html"><img src="../../ToxBut.gif" width="100" height="21" border="0"></a></td>
    <td><a href="../indexSG.html"><img src="../../SGbut.gif" width="100" height="21" border="0"></a></td>
    <td><a href="../../lectureSite/indexLec.html"><img src="../../LecBut.gif" width="100" height="21" border="0"></a></td>
    <td><a href="../../formSite/Aform.html" target="_blank"><img src="../../FormBut.gif" width="100" height="21" border="0"></a></td>
    <td><a href="../../casesSite/indexCases.html"><img src="../../CaseBut.gif" width="100" height="21" border="0"></a></td>
  </tr>
</table>
<br>
<table width="90%" border="0" align="center" cellpadding="2" cellspacing="0">
  <tr bgcolor="#FFFFFF">
    <td width="50%" class="commonname"><img src="../../pharmBits/images/mulogo.gif" width="170" height="25"></td>
    <td width="50%" align="right" class="references"><div align="right">copyright
        Massey University</div>
    </td>
  </tr>
</table>
<p>&nbsp;</p>
		<div id="gototop"><a href="#top"><b>top</b></a></div>

</div>
</body>
</html>
